CD44, EGFR and p16 expressions in oropharyngeal squamous cell cancer patients treated by IMRT.

SLÁVIK, Marek, Tetiana SHATOKHINA, Jiří ŠÁNA, Parwez AHMAD, Markéta HERMANOVÁ, Tomáš KAZDA, Pavel ŠLAMPA and Ondřej SLABÝ. CD44, EGFR and p16 expressions in oropharyngeal squamous cell cancer patients treated by IMRT. In 37th Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO). 2018. ISSN 0167-8140. Available from: https://dx.doi.org/10.1016/S0167-8140(18)32601-X.

Basic information

• Original name: CD44, EGFR and p16 expressions in oropharyngeal squamous cell cancer patients treated by IMRT.
• Authors: SLÁVIK, Marek (703 Slovakia, belonging to the institution), Tetiana SHATOKHINA (804 Ukraine, belonging to the institution), Jiří ŠÁNA (203 Czech Republic, belonging to the institution), Parwez AHMAD (356 India, belonging to the institution), Markéta HERMANOVÁ (203 Czech Republic, belonging to the institution), Tomáš KAZDA (203 Czech Republic, belonging to the institution), Pavel ŠLAMPA (203 Czech Republic, belonging to the institution) and Ondřej SLABÝ (203 Czech Republic, guarantor, belonging to the institution).
• Edition: 37th Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO), 2018.

Other information

• Original language: English
• Type of outcome: Conference abstract
• Field of Study: 30204 Oncology
• Country of publisher: Ireland
• Confidentiality degree: is not subject to a state or trade secret
• Impact factor: Impact factor: 5.252
• RIV identification code: RIV/00216224:14740/18:00106461
• Organization unit: Central European Institute of Technology
• ISSN: 0167-8140
• Doi: http://dx.doi.org/10.1016/S0167-8140(18)32601-X
• UT WoS: 000438676103049
• Keywords in English: EGFR; CD44; p16
• Tags: rivok
• Tags: International impact, Reviewed

Abstract

The aim of this study was to analyse the expression of epidermal growth factor receptor (EGFR), cluster of differentiation- 44 (CD44) and p16 in patients with oropharyngeal squamous cell carcinoma (OSCC) and correlate the expression profiles with radiation treatment outcomes.

Links

• LQ1601, research and development project: Name: CEITEC 2020 (Acronym: CEITEC2020)

Investor: Ministry of Education, Youth and Sports of the CR

• NV15-31627A, research and development project: Name: Možnosti molekulárně řízené radikální radioterapie nebo radiochemoterapie dle profilu mikroRNA u pacientů se spinocelulárními karcinomy hlavy a krku.